AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

Women's Health Weekly

| September 04, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 SEP 4 - (NewsRx.com & NewsRx.net) -- Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

"Taxanes act by inhibiting microtubule dynamics; in this study, we have investigated mitochondria as an additional target of taxanes. We incubated isolated mitochondria in the presence of taxanes with or without stimulation of the mitochondrial respiratory state," scientists in Italy report.

"Results showed that they rapidly induced the loss of deltapsi(m) after stimulation of the respiratory state. To evaluate the binding of [[superscript]14C] paclitaxel to isolated mitochondria, mitochondrial proteins were precipitated yielding 18.6 [+ or -] 2.1 cpm/microgram of protein," wrote C. Ferlini and colleagues, Sacred Heart University, Department of Obstetrics & Gynecology.

"After stimulation of the respiratory state, binding of [[superscript]14C]paclitaxel increased up to 163.2 [+ or -] 46.7 cpm/microgram of protein. CPM values after Bcl-2 immunoprecipitation was 62.8-fold higher than those of the control antibody, thereby indicating the involvement of Bcl-2 in paclitaxel binding," the researchers wrote.

"Then, we established a panel of A2780 cell lines resistant to increasing doses of paclitaxel alone or to high doses of paclitaxel/cyclosporin A A2780 TC cells). In both cases, Bcl-2 expression was consistently down-regulated, whereas levels of other members of the Bcl-2 family, such as Bax and Bcl-x, did not change in ...

Related articles from newspapers, magazines, journals, and more
Study results from D. Hermanson and colleagues update understanding of...
Newspaper article from: Drug Week October 23, 2009 700+ words
...a small-molecule Bcl-2 antagonist that...States report (see also Molecular Pharmacology). "The current study...antiapoptotic function of Bcl-2 family proteins...includes antiapoptotic Bcl-2 family proteins...published their study in Molecular Pharmacology (Dual Mechanisms of...
New molecular pharmacology research reported from M. Alken and co-authors.
Newspaper article from: Drug Week May 22, 2009 700+ words
...research published in the journal Molecular Pharmacology, "The heptahelical G protein...Alken and colleagues (see also Molecular Pharmacology). The researchers concluded...colleagues published their study in Molecular Pharmacology (The Sequence after the Signal...
New molecular pharmacology study results from University of Bath described.
Newspaper article from: Drug Week July 24, 2009 700+ words
...scientists writing in the journal Molecular Pharmacology report (see also Molecular Pharmacology). "Ibotenate was a partial agonist...colleagues published their study in Molecular Pharmacology (An Ivermectin-Sensitive Glutamate...
New molecular pharmacology research from Pfizer Inc. discussed.
Newspaper article from: Drug Week March 27, 2009 700+ words
...scientists writing in the journal Molecular Pharmacology report (see also Molecular Pharmacology). "These structurally related...colleagues published their study in Molecular Pharmacology (Molecular Characterization of...
New molecular pharmacology research reported from Purdue University.
Newspaper article from: Drug Week November 7, 2008 700+ words
...United States report (see also Molecular Pharmacology). "We have used bimolecular...colleagues published their study in Molecular Pharmacology (Ligand-dependent oligomerization...receptors in living neuronal cells. Molecular Pharmacology, 2008;74(3):544-551...
New molecular pharmacology research has been reported by T.E. Taylorclark et al.
Newspaper article from: Drug Week May 22, 2009 700+ words
...research published in the journal Molecular Pharmacology, "Transient Receptor Potential...Taylorclark and colleagues (see also Molecular Pharmacology). The researchers concluded...colleagues published their study in Molecular Pharmacology (Nitrooleic Acid, an Endogenous...
New molecular pharmacology data have been reported by researchers at University...
Newspaper article from: Drug Week December 26, 2008 700+ words
...research published in the journal Molecular Pharmacology, "Peroxisome proliferator-activated...University of Marburg (see also Molecular Pharmacology). The researchers concluded...colleagues published their study in Molecular Pharmacology (Ligand-Mediated Regulation...
New molecular pharmacology research from Cornell University, Medical Department...
Newspaper article from: Drug Week November 7, 2008 700+ words
...scientists writing in the journal Molecular Pharmacology report (see also Molecular Pharmacology). "Mutation of a single alpha...colleagues published their study in Molecular Pharmacology (Alternative splicing of the Ca2...
For more facts and information, see all results

Source: HighBeam Research, Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA